Jefferson Davis - Acer Therapeutics Chief Officer

Insider

Jefferson Davis is Chief Officer of Acer Therapeutics
Age 56
Phone844 902 6100
Webhttps://www.acertx.com

Acer Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.6527) % which means that it has lost $0.6527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7299) %, meaning that it created substantial loss on money invested by shareholders. Acer Therapeutics' management efficiency ratios could be used to measure how well Acer Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Acer Therapeutics currently holds 11.86 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Acer Therapeutics has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Acer Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Merav BassanBiomx Inc
59
Yassine BendiabdallahPasithea Therapeutics Corp
41
Christopher BunkaLexaria Bioscience Corp
62
Tomasz GeorgeVirax Biolabs Group
40
James RolkeRevelation Biosciences
56
Edward DVMSAB Biotherapeutics
N/A
LaBella MSZyVersa Therapeutics
66
CPA CMALexaria Bioscience Corp
63
Jane SpringerHoth Therapeutics
39
Eran MDBiomx Inc
N/A
Tiago MarquesPasithea Therapeutics Corp
47
Chester IIIRevelation Biosciences
45
Jonathan MBABiomx Inc
48
Karen CashmereZyVersa Therapeutics
73
Vanessa CarleLexaria Bioscience Corp
N/A
Christine MBASAB Biotherapeutics
69
Eddie SullivanSAB Biotherapeutics
59
James FosterVirax Biolabs Group
40
Alexandra MDAvenue Therapeutics
58
MD BAPasithea Therapeutics Corp
76
Assaf OronBiomx Inc
50
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. Acer Therapeutics (ACER) is traded on NASDAQ Exchange in USA and employs 30 people.

Management Performance

Acer Therapeutics Leadership Team

Elected by the shareholders, the Acer Therapeutics' board of directors comprises two types of representatives: Acer Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acer. The board's role is to monitor Acer Therapeutics' management team and ensure that shareholders' interests are well served. Acer Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acer Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jefferson Davis, Chief Officer
Jason CPA, VP Controller
John Klopp, Vice President - Manufacturing
Donald JD, Chief Sec
Bernie Paul, Chief Officer
Harry Palmin, Chief Officer
Matthew Seibt, Chief Officer
Tanya Hayden, Chief Officer
MD FFPM, Chief Officer
Christopher Schelling, President CEO, Director

Acer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acer Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Acer Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acer Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Acer Stock

If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets